Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities

European Journal of Cancer

Volumn 40, Issue 18, 2004, Pages 2667-2675

  Sørlie, Therese ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; DNA microarrays; Gene expression patterns; Individualised treatment; Prognosis

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53;

BREAST CANCER; CANCER CLASSIFICATION; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS;

EID: 9644310201     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.08.021     Document Type: Article

References (31)

1. A.J. Sasco Breast cancer and the environment Horm. Res. 60 Suppl. 3 2003 50
2. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray [see comments] Science 270 1995 467 470
3. N. Novoradovskaya, M.L. Whitfield, L.S. Basehore, A. Novoradovsky, R. Pesich, and J. Usary Universal reference RNA as a standard for microarray experiments BMC Genom. 5 2004 20
4. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proc. Natl. Acad. Sci. USA 95 1998 14863 14868
5. M.P. Brown, W.N. Grundy, D. Lin, N. Cristianini, C.W. Sugnet, and T.S. Furey Knowledge-based analysis of microarray gene expression data by using support vector machines Proc. Natl. Acad. Sci. USA 97 2000 262 267
6. J. Khan, J.S. Wei, M. Ringner, L.H. Saal, M. Ladanyi, and F. Westermann Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks Nat. Med. 7 2001 673 679
7. R. Tibshirani, T. Hastie, B. Narasimhan, and G. Chu Diagnosis of multiple cancer types by shrunken centroids of gene expression Proc. Natl. Acad. Sci. USA 99 2002 6567 6572
8. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. USA 98 2001 5116 5121
9. C.M. Perou, T. Sorlie, M.B. Eisen, R.M. Van de, S.S. Jeffrey, and C.A. Rees Molecular portraits of human breast tumours Nature 406 2000 747 752
10. T. Aas, A.L. Borresen, S. Geisler, B. Smith-Sorensen, H. Johnsen, and J.E. Varhaug Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nat. Med. 2 1996 811 814
11. S. Geisler, P.E. Lønning, T. Aas, H. Johnsen, and Ø Fluge Influence of TP53 gene alterations and c-erbB2 expression on the response to treatment with doxorubicin in locally advanced breast cancer Cancer Res. 2000
12. S. Geisler, A.L. Borresen-Dale, H. Johnsen, T. Aas, J. Geisler, and L.A. Akslen TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer Clin. Cancer Res. 9 2003 5582 5588
13. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, and A. Nobel Repeated observation of breast tumor subtypes in independent gene expression data sets Proc. Natl. Acad. Sci. USA 100 2003 8418 8423
14. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, and H. Johnsen Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. USA 98 2001 10869 10874
15. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, and M. Mao Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
16. D.T. Ross, U. Scherf, M.B. Eisen, C.M. Perou, C. Rees, and P. Spellman Systematic variation in gene expression patterns in human cancer cell lines Nat. Genet. 24 2000 227 235
17. M.L. Whitfield, G. Sherlock, A.J. Saldanha, J.I. Murray, C.A. Ball, and K.E. Alexander Identification of genes periodically expressed in the human cell cycle and their expression in tumors Mol. Biol. Cell 13 2002 1977 2000
18. E.E. Balint, and K.H. Vousden Activation and activities of the p53 tumour suppressor protein Br. J. Cancer 85 2001 1813 1823
19. D.P. Guimaraes, and P. Hainaut TP53: a key gene in human cancer Biochimie 84 2002 83 93
20. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
21. J. Bergh, T. Norberg, S. Sjogren, A. Lindgren, and L. Holmberg Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Nat. Med. 1 1995 1029 1034
22. E.M. Berns, J.A. Foekens, R. Vossen, M.P. Look, P. Devilee, and S.C. Henzen-Logmans Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer Cancer Res. 60 2000 2155 2162
23. A.L. Borresen, T.I. Andersen, J.E. Eyfjord, R.S. Cornelis, S. Thorlacius, and A. Borg TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains genes chromosomes Cancer 14 1995 71 75
24. L.L. Nakopoulou, A. Alexiadou, G.E. Theodoropoulos, A.C. Lazaris, A. Tzonou, and A. Keramopoulos Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer J. Pathol. 179 1996 31 38
25. I. Hedenfalk, D. Duggan, Y. Chen, M. Radmacher, M. Bittner, and R. Simon Gene-expression profiles in hereditary breast cancer N. Engl. J. Med. 344 2001 539 548
26. J.E. Armes, L. Trute, D. White, M.C. Southey, F. Hammet, and A. Tesoriero Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study Cancer Res. 59 1999 2011 2017
27. T.A. Grushko, M.A. Blackwood, P.L. Schumm, F.G. Hagos, M.O. Adeyanju, and M.D. Feldman Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers Cancer Res. 62 2002 1481 1488
28. S. Fan, J. Wang, R. Yuan, Y. Ma, Q. Meng, and M.R. Erdos BRCA1 inhibition of estrogen receptor signaling in transfected cells Science 284 1999 1354 1356
29. M. Razandi, A. Pedram, E.M. Rosen, and E.R. Levin BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer Mol. Cell. Biol. 24 2004 5900 5913
30. E. Hyman, P. Kauraniemi, S. Hautaniemi, M. Wolf, S. Mousses, and E. Rozenblum Impact of DNA amplification on gene expression patterns in breast cancer Cancer Res. 62 2002 6240 6245
31. J.R. Pollack, T. Sorlie, C.M. Perou, C.A. Rees, S.S. Jeffrey, and P.E. Lonning Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors Proc. Natl. Acad. Sci. USA 99 2002 12963 12968